These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3552795)

  • 1. Mechanism of metformin action in non-insulin-dependent diabetes.
    Jackson RA; Hawa MI; Jaspan JB; Sim BM; Disilvio L; Featherbe D; Kurtz AB
    Diabetes; 1987 May; 36(5):632-40. PubMed ID: 3552795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of aging on hepatic and peripheral glucose metabolism in humans.
    Jackson RA; Hawa MI; Roshania RD; Sim BM; DiSilvio L; Jaspan JB
    Diabetes; 1988 Jan; 37(1):119-29. PubMed ID: 3275553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bedtime insulin for suppression of overnight free-fatty acid, blood glucose, and glucose production in NIDDM.
    Taskinen MR; Sane T; Helve E; Karonen SL; Nikkilä EA; Yki-Järvinen H
    Diabetes; 1989 May; 38(5):580-8. PubMed ID: 2653929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
    DeFronzo RA; Barzilai N; Simonson DC
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin improves peripheral but not hepatic insulin action in obese patients with type II diabetes.
    Hother-Nielsen O; Schmitz O; Andersen PH; Beck-Nielsen H; Pedersen O
    Acta Endocrinol (Copenh); 1989 Mar; 120(3):257-65. PubMed ID: 2648723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
    Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA
    Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of metformin treatment on whole-body and splanchnic amino acid turnover in mild type 2 diabetes.
    Tessari P; Biolo G; Bruttomesso D; Inchiostro S; Panebianco G; Vedovato M; Fongher C; Tiengo A
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1553-60. PubMed ID: 7989455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of metformin on adipose tissue metabolism and peripheral blood flow in subjects with NIDDM.
    Jansson PA; Gudbjörnsdóttir HS; Andersson OK; Lönnroth PN
    Diabetes Care; 1996 Feb; 19(2):160-4. PubMed ID: 8718438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin normalizes nonoxidative glucose metabolism in insulin-resistant normoglycemic first-degree relatives of patients with NIDDM.
    Widén EI; Eriksson JG; Groop LC
    Diabetes; 1992 Mar; 41(3):354-8. PubMed ID: 1551495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics.
    Baron AD; Schaeffer L; Shragg P; Kolterman OG
    Diabetes; 1987 Mar; 36(3):274-83. PubMed ID: 2879757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low dose metformin in the treatment of type II non-insulin-dependent diabetes: clinical and metabolic evaluations.
    Gregorio F; Ambrosi F; Marchetti P; Cristallini S; Navalesi R; Brunetti P; Filipponi P
    Acta Diabetol Lat; 1990; 27(2):139-55. PubMed ID: 2198745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at a postreceptor site in hepatic as well as extrahepatic tissues.
    Mandarino LJ; Gerich JE
    Diabetes Care; 1984; 7 Suppl 1():89-99. PubMed ID: 6376034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of fasting on plasma glucose and prolonged tracer measurement of hepatic glucose output in NIDDM.
    Glauber H; Wallace P; Brechtel G
    Diabetes; 1987 Oct; 36(10):1187-94. PubMed ID: 3308588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridaemia and non-insulin dependent diabetes by glucose tolerance test criteria.
    Hollenbeck CB; Johnston P; Varasteh BB; Chen YD; Reaven GM
    Diabete Metab; 1991; 17(5):483-9. PubMed ID: 1752350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of basal insulin supplementation on disposition of mixed meal in obese patients with NIDDM.
    McMahon M; Marsh HM; Rizza RA
    Diabetes; 1989 Mar; 38(3):291-303. PubMed ID: 2492963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes.
    Nosadini R; Avogaro A; Trevisan R; Valerio A; Tessari P; Duner E; Tiengo A; Velussi M; Del Prato S; De Kreutzenberg S
    Diabetes Care; 1987; 10(1):62-7. PubMed ID: 3552515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of insulin sensitivity by metformin treatment does not lower blood pressure of nonobese insulin-resistant hypertensive patients with normal glucose tolerance.
    Dorella M; Giusto M; Da Tos V; Campagnolo M; Palatini P; Rossi G; Ceolotto G; Felice M; Semplicini A; Del Prato S
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1568-74. PubMed ID: 8636369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin increases insulin sensitivity and basal glucose clearance in type 2 (non-insulin dependent) diabetes mellitus.
    McIntyre HD; Ma A; Bird DM; Paterson CA; Ravenscroft PJ; Cameron DP
    Aust N Z J Med; 1991 Oct; 21(5):714-9. PubMed ID: 1759920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose and lipid metabolism in non-insulin-dependent diabetes. Effect of metformin.
    Riccio A; Del Prato S; Vigili de Kreutzenberg S; Tiengo A
    Diabete Metab; 1991 May; 17(1 Pt 2):180-4. PubMed ID: 1936473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No reduction in total hepatic glucose output by inhibition of gluconeogenesis with ethanol in NIDDM patients.
    Puhakainen I; Koivisto VA; Yki-Järvinen H
    Diabetes; 1991 Oct; 40(10):1319-27. PubMed ID: 1936594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.